Twinbeech Capital LP Pacific Biosciences Of California, Inc. Transaction History

Twinbeech Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $207,726 - $360,476	34,795 Added 97.85%	70,355 $690,000
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $292,658 - $495,350	35,560 New	35,560 $296,000
Q2 2022 Aug 15, 2022	SELL	$4.02 - $10.43 $1.29 Million - $3.34 Million	-320,159 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.43 - $20.9 $2.7 Million - $6.69 Million	320,159 New	320,159 $2.91 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.